Skip to contentB
Bio-Rad Laboratories, Inc.
B
BIOBio-Rad Laboratories, Inc. Q2 2012 · 10-Q
Revenue$510.42M$510.42M−2.2% vs Q2 2011 Net Income$48.34M$48.34M+20.9% vs Q2 2011 EPS Diluted$1.69$1.69+19.9% vs Q2 2011 Gross Profit$287,900,000−1.8% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio-Rad Laboratories, Inc. · CIK 12208 · Engraved from SEC EDGAR
Operating Cash Flowderived$73,642,000−33.2% Free Cash Flowderived$32,599,000−61.9% Margins · derivedGross margin56.4%+0.2 pt vs Q2 2011
Operating margin14.4%+1.3 pt vs Q2 2011
Net margin9.5%+1.8 pt vs Q2 2011
ended Jun 30, 2012 · filed Aug 9, 2012 · 40 d after period end